Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors
Purpose: Radiation-induced lymphopenia (RIL) is the result of direct toxicity to circulating lymphocytes as they traverse the irradiated field, occurs in 40% to 70% of patients who undergo conventional external beam radiation therapy, and is associated with worse outcomes in multiple solid tumors. A...
Main Author: | Susannah G. Ellsworth, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-10-01
|
Series: | Advances in Radiation Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452109418301465 |
Similar Items
-
Radiation-Induced Lymphopenia Risks of Photon Versus Proton Therapy for Esophageal Cancer Patients
by: Saba Ebrahimi, BSc, et al.
Published: (2021-04-01) -
Lymphopenia, Lymphopenia-Induced Proliferation, and Autoimmunity
by: Ting-Ting Sheu, et al.
Published: (2021-04-01) -
Prognosis and Risk Factors of Radiation-Induced Lymphopenia in Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy
by: Qianqian Zhao, et al.
Published: (2020-01-01) -
Radiation-Induced Lymphopenia Beyond the COVID-19 Pandemic
by: Giuseppe Carlo Iorio, et al.
Published: (2020-11-01) -
Radiation-related Lymphopenia after Pelvic Nodal Irradiation for Prostate Cancer
by: Michael D. Schad, BS, et al.
Published: (2019-04-01)